Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis

Biochim Biophys Acta Mol Cell Res. 2020 Nov;1867(11):118806. doi: 10.1016/j.bbamcr.2020.118806. Epub 2020 Jul 31.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive and fibrosing interstitial pneumonia of unknown cause. The main feature of IPF is a heterogeneous appearance with areas of sub-pleural fibrosis. However, the mechanism of sub-pleural fibrosis was poorly understood. In this study, our in vivo study revealed that pleural mesothelial cells (PMCs) migrated into lung parenchyma and localized alongside lung fibroblasts in sub-pleural area in mouse pulmonary fibrosis. Our in vitro study displayed that cultured-PMCs-medium induced lung fibroblasts transforming into myofibroblast, cultured-fibroblasts-medium promoted mesothelial-mesenchymal transition of PMCs. Furthermore, these changes in lung fibroblasts and PMCs were prevented by blocking TGF-β1/Smad2/3 signaling with SB431542. TGF-β1 neutralized antibody attenuated bleomycin-induced pulmonary fibrosis. Similar to TGF-β1/Smad2/3 signaling, wnt/β-catenin signaling was also activated in the process of PMCs crosstalk with lung fibroblasts. Moreover, inhibition of CD147 attenuated cultured-PMCs-medium induced collagen-I synthesis in lung fibroblasts. Blocking CD147 signaling also prevented bleomycin-induced pulmonary fibrosis. Our data indicated that crosstalk between PMC and lung fibroblast contributed to sub-pleural pulmonary fibrosis. TGF-β1, Wnt/β-catenin and CD147 signaling was involved in the underling mechanism.

Keywords: CD147; Idiopathic pulmonary fibrosis (IPF); Lung fibroblasts; Pleural mesothelial cells (PMCs); TGF-β1; Wnts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzamides / pharmacology
  • Cell Movement / genetics
  • Dioxoles / pharmacology
  • Disease Models, Animal
  • Epithelial Cells / drug effects
  • Epithelium / drug effects*
  • Epithelium / pathology
  • Fibroblasts / drug effects
  • Gene Expression Regulation / drug effects
  • Humans
  • Lung / drug effects
  • Lung / metabolism*
  • Lung / pathology
  • Mice
  • Pleura / drug effects*
  • Pleura / metabolism
  • Pulmonary Fibrosis / genetics*
  • Pulmonary Fibrosis / metabolism
  • Pulmonary Fibrosis / pathology
  • Signal Transduction / drug effects
  • Smad2 Protein / genetics
  • Transforming Growth Factor beta1 / genetics

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • Benzamides
  • Dioxoles
  • Smad2 Protein
  • Smad2 protein, mouse
  • Transforming Growth Factor beta1